Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
Northwest Biotherapeutics is establishing a dedicated leukapheresis clinic at The London Welbeck Hospital to proactively address capacity constraints and support the scale-up of its DCVax programs. The facility is designed to handle 4 patients per day with built-in flexibility for extended hours and weekend operations, with buildout expected to finish by June.
Key figures
- Daily capacity patients
- 4
- Buildout completion month
- June
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.